CoChat

Individualized clinical management of patients at risk for Alzheimer's dementia

Open access
Isaacson, Richard S., Hristov, Hollie, Saif, Nabeel, Hackett, Katherine, Hendrix, Suzanne, Melendez, Juan, Safdieh, Joseph, Fink, Matthew, Thambisetty, Madhav, Sadek, George, Bellara, Sonia, Lee, Paige, Berkowitz, Cara, Rahman, Aneela, Meléndez‐Cabrero, Josefina, Caesar, Emily, Cohen, Randy, Lu, Pei‐lin, Dickson, Samuel P., Hwang, Mu Ji, Scheyer, Olivia, Mureb, Monica, Schelke, Matthew W., Niotis, Kellyann, Greer, Christine E., Attia, Peter, Mosconi, Lisa, Krikorian, Robert · 2019 · Alzheimer's & Dementia
Cited by 76

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Introduction: Multidomain intervention for Alzheimer's disease (AD) risk reduction is an emerging therapeutic paradigm. Methods: Patients were prescribed individually tailored interventions (education/pharmacologic/nonpharmacologic) and rated on compliance. Normal cognition/subjective cognitive decline/preclinical AD was classified as Prevention. Mild cognitive impairment due to AD/mild‐AD was classified as Early Treatment. Change from baseline to 18 months on the modified Alzheimer's Prevention Cognitive Composite (primary outcome) was compared against matched historical control cohorts. Cognitive aging composite (CogAging), AD/cardiovascular risk scales, and serum biomarkers were secondary outcomes. Results: One hundred seventy‐four were assigned interventions (age 25–86). Higher‐compliance Prevention improved more than both historical cohorts (P = .0012, P < .0001). Lower‐compliance Prevention also improved more than both historical cohorts (P = .0088, P < .0055). Higher‐compliance Early Treatment improved more than lower compliance (P = .0007). Higher‐compliance Early Treatment improved more than historical cohorts (P < .0001, P = .0428). Lower‐compliance Early Treatment did not differ (P = .9820, P = .1115). Similar effects occurred for CogAging. AD/cardiovascular risk scales and serum biomarkers improved. Discussion: Individualized multidomain interventions may improve cognition and reduce AD/cardiovascular risk scores in patients at‐risk for AD dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.08.198

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 76

Metadata

Authors
Isaacson, R. S., Hristov, H., Saif, N., Hackett, K., Hendrix, S., Melendez, J., Safdieh, J., Fink, M., Thambisetty, M., Sadek, G., Bellara, S., Lee, P., Berkowitz, C., Rahman, A., Meléndez‐Cabrero, J., Caesar, E., Cohen, R., Lu, P., Dickson, S. P., Hwang, M. J., Scheyer, O., Mureb, M., Schelke, M. W., Niotis, K., Greer, C. E., Attia, P., Mosconi, L., & Krikorian, R.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2019-10-30
Volume
15
Issue
12
Pages
1588-1602
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2982498870
Cited by
76
References
18
FWCI
6.33
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individualized clinical management of patients at risk for Alzheimer's dementia. https://app.cochat.ai/papers/10.1016/j.jalz.2019.08.198
The paper
Isaacson, R. S., Hristov, H., Saif, N., Hackett, K., Hendrix, S., Melendez, J., Safdieh, J., Fink, M., Thambisetty, M., Sadek, G., Bellara, S., Lee, P., Berkowitz, C., Rahman, A., Meléndez‐Cabrero, J., Caesar, E., Cohen, R., Lu, P., Dickson, S. P., . . . Krikorian, R. (2019). Individualized clinical management of patients at risk for Alzheimer's dementia. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2019.08.198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.